本页面由Tiger Trade Technology Pte. Ltd.提供服务

Processa Pharmaceuticals, Inc.

2.59
-0.0100-0.38%
盘后2.52-0.0700-2.70%19:34 EDT
成交量:6.14万
成交额:16.31万
市值:716.91万
市盈率:-0.24
高:2.74
开:2.69
低:2.53
收:2.60
52周最高:14.24
52周最低:1.67
股本:276.80万
流通股本:266.84万
量比:0.63
换手率:2.30%
股息:- -
股息率:- -
每股收益(TTM):-10.9007
每股收益(LYR):-96.8176
净资产收益率:-464.99%
总资产收益率:-193.89%
市净率:2.82
市盈率(LYR):-0.03

数据加载中...

公司资料

公司名字:
Processa Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
2015
员工人数:
12
公司地址:
601 21st Street,Suite 300,Vero Beach,Florida,United States
邮编:
32960
电话:
传真:
443 288 4420
简介:
Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司,正在开发下一代癌症治疗小分子管线,其中两个正在进行或已完成2期试验,一个正在进行临床前开发。

董事

名称
职位
George Ng
Chief Executive Officer and Director
Justin Yorke
Chairman of the Board and Director
David Young
Director and President of Research and Development
Geraldine Pannu
Director
James Neal
Director
Khoso Baluch
Director

股东

名称
职位
George Ng
Chief Executive Officer and Director
Russell Skibsted
Chief Financial Officer
David Young
Director and President of Research and Development
Patrick Lin
Chief Business and Strategy Officer
Wendy Guy
Chief Administrative Officer